Evidence map›Paper›PMID 41657375›Full record

ArticleAmerican journal of ophthalmology case reports2026

Bilateral myelin oligodendrocyte glycoprotein antibody-associated disease after cataract surgery.

Benjamin Besse, Amélie Dos Santos, Mathieu Mille, Francois Bobin, Hugo Schultz, Aline Berthomet, Léo Niemerich, Anna Muszalski, Favia Gianrocco, Nicolas Leveziel

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Benjamin BesseDepartment of Ophthalmology, CHU Poitiers, France.
Amélie Dos SantosDepartment of Neurology, CHU Poitiers, France.
Mathieu MilleDepartment of Neurology, CHU Poitiers, France.
Francois BobinPolyclinique de Poitiers, France.
Hugo SchultzDepartment of Ophthalmology, CHU Poitiers, France.
Aline BerthometDepartment of Neurophysiology, CHU Poitiers, France.
Léo NiemerichDepartment of Ophthalmology, CHU Poitiers, France.
Anna MuszalskiDepartment of Ophthalmology, CHU Poitiers, France.
Favia GianroccoDepartment of Radiology, CHU Poitiers, France.
Nicolas LevezielDepartment of Ophthalmology, CHU Poitiers, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To report an unusual presentation of bilateral myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) associated with optic neuritis occurring during the early post-operative cataract surgical period. Methods: This was an observational case report. Results: A 67-year-old Caucasian female presented with right eye visual acuity decrease occurring five days after bilateral cataract surgery. She also reported moderate pain associated with eye movements. While no inflammation could be observed, bilateral optic disc edema was observed on fundus examinations. Fluorescein angiography showed leakage of dye at late phases at the optic nerves, with no retinal vasculitis or choroidal ischemia on either eye. Orbit and brain magnetic resonance imaging showed bilateral optic perineuritis. Cerebrospinal fluid analysis was normal, as was the opening pressure (<25 cm of water) measured during lumbar puncture. Blood testing revealed MOGAD Immunoglobulin G (IgG) autoantibodies at a titer >1:100. Conclusion: This report describes an atypical presentation of MOGAD associated with bilateral optic neuritis occurring a few days after cataract surgery.

Indexed as

AIONCataractMOGADMyelin oligodendrocyte glycoprotein antibody-associated diseaseNAIONOptic neuritis

Identifiers

PMID41657375
PMCPMC12876305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.